Seelos Therapeutics, Inc. (SEEL) Social Stream
SEELOS THERAPEUTICS INC (SEEL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SEELOS THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 6 | $14 | $6 | $9.5 | $0.131 | 7151.91% |
| 2022-01-21 | 6 | $14 | $5 | $7.833 | $0.131 | 5879.39% |
| 2022-03-08 | 5 | $14 | $3 | $7.4 | $0.131 | 5548.85% |
| 2022-03-11 | 3 | $8 | $3 | $5.25 | $0.131 | 3907.63% |
| 2022-06-16 | 4 | $8 | $3 | $5.25 | $0.131 | 3907.63% |
| 2022-11-17 | 2 | $6 | $3 | $4.5 | $0.131 | 3335.11% |
| 2022-12-14 | 3 | $6 | $3 | $4.333 | $0.131 | 3207.63% |
| 2023-03-30 | 2 | $4 | $3 | $3.5 | $0.131 | 2571.76% |
| 2023-05-15 | 4 | $4 | $4 | $4 | $0.131 | 2953.44% |
| 2023-05-16 | 2 | $4 | $2 | $3.333 | $0.131 | 2444.27% |
| 2023-08-15 | 3 | $4 | $2 | $3.333 | $0.131 | 2444.27% |
| 2023-09-21 | 3 | $4 | $1 | $2.5 | $0.131 | 1808.4% |
The Trend in the Analyst Price Target
SEEL's average price target has moved down $5.5 over the prior 33 months.
SEEL reports an average of 403.38% for its upside potential over the past 40 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-30 | 2 | 4 | 3 | 3.500 | 0.692 | 405.78% |
| 2023-07-11 | 3 | 4 | 2 | 3.333 | 1.270 | 162.44% |
| 2023-08-15 | 3 | 4 | 2 | 3.333 | 1.170 | 184.87% |
| 2023-09-21 | 4 | 4 | 1 | 2.500 | 0.190 | 1215.79% |
| 2023-09-21 | 3 | 4 | 1 | 2.500 | 0.190 | 1215.79% |
SEEL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 2 | 0 | 2 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 13 months, SEEL's average broker recommendation rating worsened by 1.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SEEL as an investment opportunity.
- In the context of all US stocks, SEELOS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1585.41% of them.
- In the context of all US stocks, SEELOS THERAPEUTICS INC's average analyst price target is higher than 63.01% of them.
- SEELOS THERAPEUTICS INC's number of analysts covering the stock is higher than 218.82% of Healthcare stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, SEELOS THERAPEUTICS INC's variance in analysts' estimates is lower than -1007.07% of them.
Stocks similar to SEELOS THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SIGA, ASRT, and CASI.
View All Top Stocks by Price Target
Is SEEL a Buy, Hold or Sell? See the POWR Ratings now!